Almost 60 reported illnesses and 14 hospitalizations across the United States and Canada have triggered a recall of salmonella-tainted cantaloupes.
Blank Rome LLP has added a new intellectual property litigation partner to its ranks, as the firm continues to bolster its IP practice in Philadelphia and nationwide.
A district judge has approved the dismissal of a patent dispute between Eli Lilly & Co. and Synthon Laboratories Inc. in federal court in Virginia despite objections from one of Synthon's co-defendants facing similar claims in another district.
In a boost to Ford Motor Co., a New Jersey state appeals court has reversed a lower court's award of $11.8 million to a man who was injured when a a flatbed truck's rear guard failed to stop his Ford Taurus from sliding under the truck's undercarriage in an accident.
A federal judge dismissed Ranbaxy Laboratories Ltd.'s motion for summary judgment Monday in a patent infringement suit launched by Roche Palo Alto LLC over Roche's patent for Valcyte, an antiviral drug.
The New Jersey Senate was forced to postpone a vote on proposed family-leave legislation after the state's Assembly Appropriations Committee amended the bill to strengthen protections to small businesses and increase penalties for workers cheating the program.
Amgen Inc. and Wyeth Pharmaceuticals faced more bad news Monday, as the drugmakers added the strongest possible warning to Enbrel's package insert label in the wake of studies indicating that the popular rheumatoid arthritis and psoriasis treatment may increase the risk of tuberculosis and other serious infections.
Seyfarth Shaw LLP has expanded its labor and employment presence in New York, adding five new attorneys, formerly from Greenberg Traurig LLP, in the past few weeks.
Bankrupt W.R. Grace & Co. has struck a deal with the U.S. government that would split the costs of cleaning up hazardous substances that contaminated a site near Baltimore.
A federal appeals court has determined that a bankruptcy trust for a software company is not preempted by federal securities law from bringing state and foreign claims against two Swiss banks.
If Merck & Co.'s $4.85 billion agreement over painkiller Vioxx gains approval despite criticism over some facets of the deal, many experts believe the deal may be the new model for settling future mass torts litigation.
A federal district court has ruled against New Jersey environmental regulators in their wrangling with W.R. Grace & Co. over asbestos liabilities, upholding a bankruptcy court's earlier ruling that denied the state's claims.
Two JP Morgan Chase & Co. employees, one current and one former, have filed a proposed collective action against the company alleging that it failed to pay them back wages for overtime when it reclassified their jobs as protected under the Fair Labor Standards Act.
Sanofi-Aventis filed suit Friday against Sandoz Inc., the generics subsidiary of Novartis AG, in an effort to keep Sandoz from marketing its own version of Sanofi's popular insomnia drug Ambien CR.
Florida runs the highest risk of litigation and tort costs, while North Dakota is most likely to avoid these legal pitfalls, according to a research institute study that ranked the tort systems of all 50 states.
Patent-holding company Digital Technology Licensing LLC has settled its infringement lawsuit against Cingular Wireless LLC and granted Cingular a license to the patent in issue, which covers signal encoding technology used in cell phones, DTL announced Monday.
Members of the U.S. House of Representatives have introduced legislation aimed at overturning the U.S. Environmental Protection Agency's recent decision that California cannot impose its own strict regulations on greenhouse gas emissions from vehicles.
A federal appeals court handed down a split decision Friday in Teva Pharmaceuticals' challenge to Pfizer Inc.'s patents for its blockbuster arthritis drug Celebrex, upholding two of Pfizer's three disputed patents while tossing the third as invalid.
Impax Laboratories Inc. President and Chief Executive Larry Hsu has alleged that Pfizer Inc.'s recent patent suit against Impax over urinary incontinence treatment Detrol LA is a ploy to fend off generic competition in the $857 million annual U.S. market for the drug.
A judge has signed off on an $80 million sale of the bulk of assets of bankrupt Fortunoff Fine Jewelry and Silverware LLC to an affiliate of NRDC Equity Partners LLC in an agreement begrudgingly accepted by creditors.